• Bioretec will host a media event in Tampere on Sept. 2, 2026, marking global sales of more than 500,000 Activa bioresorbable orthopedic implants.
• The program includes a production-site tour at its Tampere facility, highlighting manufacturing scale-up and its bioresorbable implant technology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioretec Oyj published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.